– Study Achieved Primary Endpoint of mPFS in Patients Treated with Ficlatuzumab/Cetuximab (ERBITUX®) Combination –…
– Patients Treated with Tivozanib in TIVO-3 Study Demonstrated Over 20 Months Median DOR; OS…
Dragonfly, Braintrace’s Proprietary Network Detection and Response (NDR) Application, Is Recognized for Its Early Malware…
Google is moving workloads between data centers to boost its use of renewable energy, shifting…
Google will soon begin using geothermal energy to power its data centers in Nevada with…
Exceeded Guidance for Fiscal Year 2021 Raises Fiscal Year 2022 Guidance AUSTIN, Texas–(BUSINESS WIRE)–E2open Parent…
NEW YORK & MUMBAI, India–(BUSINESS WIRE)–#BPM–WNS (Holdings) Limited (NYSE: WNS), a leading provider of global…
Company to Review Reported Fiscal Third Quarter 2021 Financial Results & Introduce New Business Initiatives…
MINNEAPOLIS–(BUSINESS WIRE)–The CIBMTR® (Center for International Blood and Marrow Transplant Research®) announces the launch of…
Fourth quarter consolidated net sales of $314.7 million, up 30.4%, including $17.7 million from the…